Avricore Health Inc. (TSXV:AVCR)
0.0550
+0.0050 (10.00%)
Jun 11, 2026, 3:03 PM EST
Avricore Health Revenue
Avricore Health had revenue of 44.32K CAD in the quarter ending March 31, 2026, a decrease of -89.79%. This brings the company's revenue in the last twelve months to 144.14K, down -96.48% year-over-year. In the year 2025, Avricore Health had annual revenue of 533.88K, down -88.84%.
Revenue (ttm)
144.14K
Revenue Growth
-96.48%
P/S Ratio
38.65
Revenue / Employee
n/a
Employees
n/a
Market Cap
5.57M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 533.88K | -4.25M | -88.84% |
| Dec 31, 2024 | 4.79M | 1.30M | 37.32% |
| Dec 31, 2023 | 3.49M | 1.72M | 97.08% |
| Dec 31, 2022 | 1.77M | 1.65M | 1,339.95% |
| Dec 31, 2021 | 122.81K | 89.78K | 271.81% |
| Dec 31, 2020 | 33.03K | 30.00 | 0.09% |
| Dec 31, 2019 | 33.00K | 17.71K | 115.76% |
| Dec 31, 2018 | 15.30K | -2.14M | -99.29% |
| Dec 31, 2017 | 2.15M | -1.32M | -38.00% |
| Dec 31, 2016 | 3.48M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionAvricore Health News
- 22 days ago - Avricore Health Announces $1.25 Million Financing - GlobeNewsWire
- 7 weeks ago - Avricore Health Achieves Milestones and Outlines UK Expansion Roadmap for HealthTab™ Platform - GlobeNewsWire
- 5 months ago - HealthTab™ to Expand Across North East London - GlobeNewsWire
- 1 year ago - Avricore Grants Options - GlobeNewsWire
- 1 year ago - Avricore Appoints Rodger Seccombe as CEO - GlobeNewsWire
- 1 year ago - AVRICORE HEALTH CORPORATE UPDATE: Q1 Results and Ongoing Progress Report - GlobeNewsWire
- 1 year ago - AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track - GlobeNewsWire
- 1 year ago - HealthTab™ and Patients Know Best® Bring Pharmacy-Based Blood Test Results to Millions in UK - GlobeNewsWire